All In MedTech

FDA Clearance Tracker · P000040

HYDRO THERMABLATOR ENDOMETRIAL ABLATION SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Apr 20, 2001 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P000040
Device name
HYDRO THERMABLATOR ENDOMETRIAL ABLATION SYSTEM
Applicant location
Jacksonville, FL
Received
Sep 25, 2000
Decided
Apr 20, 2001
Decision
Approved
Supplements
42 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code MNB

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE HYDRO THERMABLATOR(R) ENDOMETRIAL ABLATION SYSTEM. THE DEVICE IS INTENDED TO ABLATE THE ENDOMETRIAL LINING OF THE UTERUS IN PREMENOPAUSAL WOMEN WITH MENORRHAGIA (EXCESSIVE UTERINE BLEEDING) DUE TO BENIGN CAUSES FOR WHOM CHILD BEARING IS COMPLETE.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MNB. The earliest in FDA's data is P970021, decided Dec 12, 1997.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Axora Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.